Research Output | Dar Al-hikmah Library | IIUM Only
Introduction: The oral medication of remdesivir and hydroxychloroquineface several limitations in covid-19 therapy. Despite having the first-pass metabolism, it also has a limitation in the patient who has hospitalised with a severe covid-19 infection. It is especially for a drug that is targeting the angiotensin-converting enzyme II (ACE2) recepto